Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Crinetics Pharmaceuticals, Inc. (CRNX)
USD83.67
+0.09 (+0.11%)
US NASDAQ Healthcare Biotechnology
Address
Building No. 2 92121
San Diego, CA, US
San Diego, CA, US
CEO
R. Scott Struthers
Website
crinetics.com
IPO
2018-07-18
CIK 1658247 ISIN US22663K1079
Description
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
News Sentiment (7d)
22 articles
- Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. The Motley Fool
- Vertex's Crinetics Deal Balances Growth with Integration Risk MarketBeat
- Crinetics shares surge after Vertex agrees to $10B cash buyout Invezz
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion WSJ
- Why This Pharmaceutical Stock Jumped Close to 100% This Week Fool - Investing News
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD83.67
+0.09 (+0.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.23
Float Shares
96.25M
Free Float %
91.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.48% | -12.83% | -7.33% | -17.08% | -14.64% | -21.48% | +9.69% | +64.71% | +121.78% | +49.12% | +49.12% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (18 ratings, all time)
Buy
Price Targets & DCF
Current price
83.67
Low
67.00
-19.9%
Consensus
86.17
+3.0%
Median
85.50
+2.2%
High
105.00
+25.5%
Ratings Trend (MoM)
93% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 11 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 10 |
85.10
+1.7%
|
| All Time | 21 |
75.57
-9.7%
|
Quality scores
Altman Z-Score
17.42
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+640.7% ★ Q1'26: +2,873.4% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-34.2% Q1'26: -18.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-6,654.2% Q1'26: -1,169.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-6,714.8% Q1'26: -1,307.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-4,057.9% Q1'26: -1,509.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+16.4% Q1'26: +11.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.09× Q1'26: -0.09× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 8 EPS Ana. |
Dec 2027 10 Rev. Ana. 9 EPS Ana. |
Dec 2028 7 Rev. Ana. 5 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.43M
est: 1.86M (+30.6%)
|
1.19M
est: 1.01M (+18.0%)
|
71.0K
est: 85.5K (-17.0%)
|
4.74M
est: 4.26M (+11.2%)
|
4.01M
est: 1.39M (+189.7%)
|
1.04M
est: 1.63M (-36.2%)
|
7.70M
est: 6.33M (+21.6%)
|
67.69M
62.82M – 72.82M
+969.6% YoY
|
172.86M
135.33M – 216.66M
+155.4% YoY
|
420.18M
419.18M – 421.17M
+143.1% YoY
|
915.96M
692.90M – 1.10B
+118.0% YoY
|
1.56B
1.18B – 1.88B
+70.3% YoY
|
| EBITDA |
-28.24M
est: -1.86M (-1,418.7%)
|
-49.31M
est: -1.01M (-4,777.3%)
|
-74.01M
est: -85.5K (-86,455.6%)
|
-166.90M
est: -4.26M (-3,818.4%)
|
-221.51M
est: -1.39M (-15,893.5%)
|
-336.07M
est: -1.63M (-20,550.9%)
|
-512.88M
est: -6.33M (-8,004.6%)
|
-67.69M
-72.82M – -62.82M
-969.6% YoY
|
-172.86M
-216.66M – -135.33M
-155.4% YoY
|
-420.18M
-421.17M – -419.18M
-143.1% YoY
|
-915.96M
-1.10B – -692.90M
-118.0% YoY
|
-1.56B
-1.88B – -1.18B
-70.3% YoY
|
| EBIT |
-27.12M
est: -1.86M (-1,358.3%)
|
-53.83M
est: -1.01M (-5,224.6%)
|
-74.95M
est: -85.5K (-87,564.3%)
|
-167.88M
est: -4.26M (-3,841.5%)
|
-222.61M
est: -1.39M (-15,972.8%)
|
-338.85M
est: -1.63M (-20,722.0%)
|
-516.77M
est: -6.33M (-8,066.1%)
|
-67.69M
-72.82M – -62.82M
-969.6% YoY
|
-172.86M
-216.66M – -135.33M
-155.4% YoY
|
-420.18M
-421.17M – -419.18M
-143.1% YoY
|
-915.96M
-1.10B – -692.90M
-118.0% YoY
|
-1.56B
-1.88B – -1.18B
-70.3% YoY
|
| Net Income |
-27.12M
est: -229.26M (+88.2%)
|
-49.54M
est: -174.76M (+71.7%)
|
-73.81M
est: -190.00M (+61.2%)
|
-163.92M
est: -183.89M (+10.9%)
|
-214.53M
est: -258.54M (+17.0%)
|
-298.41M
est: -369.83M (+19.3%)
|
-465.32M
est: -465.32M (+0.0%)
|
-494.99M
-545.85M – -262.34M
-6.4% YoY
|
-454.49M
-523.48M – -275.02M
+8.2% YoY
|
-304.71M
-342.14M – -90.69M
+33.0% YoY
|
78.82M
53.87M – 99.76M
+125.9% YoY
|
421.94M
288.36M – 534.02M
+435.3% YoY
|
| SGA |
6.66M
est: 147.29M (-95.5%)
|
13.52M
est: 80.08M (-83.1%)
|
18.03M
est: 6.77M (+166.2%)
|
42.39M
est: 337.39M (-87.4%)
|
58.09M
est: 46.27M (+25.6%)
|
99.74M
est: 54.36M (+83.5%)
|
191.33M
est: 211.40M (-9.5%)
|
2.26B
2.10B – 2.43B
+969.6% YoY
|
5.77B
4.52B – 7.24B
+155.4% YoY
|
14.04B
14.00B – 14.07B
+143.1% YoY
|
30.60B
23.15B – 36.85B
+118.0% YoY
|
52.10B
39.41B – 62.75B
+70.3% YoY
|
| EPS |
-2.23
est: -2.84 (+21.4%)
|
-2.05
est: -2.16 (+5.2%)
|
-2.42
est: -2.35 (-2.9%)
|
-3.15
est: -3.16 (+0.5%)
|
-3.69
est: -3.75 (+1.7%)
|
-3.69
est: -3.69 (+0.0%)
|
-4.95
est: -5.03 (+1.6%)
|
-4.84
-5.80 – -2.79
+3.7% YoY
|
-4.28
-5.57 – -2.92
+11.8% YoY
|
-2.42
-3.64 – -0.96
+43.5% YoY
|
0.84
0.57 – 1.06
+134.7% YoY
|
4.49
3.07 – 5.68
+435.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-28 | Citizens | Market Outperform | Market Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-282.85M
OE per share TTM
-2.98
Owner's Yield
-6.25%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
955.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
48
Total invested
175.93M
Insider transactions (90d)
0
Beneficial owners (>5%)
44
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Joseph Edelman | 5.33M | 10.00% | — | 5.33M | — | 5.33M | IN | — | 2022-04-21 | ↗ |
| 2 | Perceptive Advisors LLC | 5.33M | 10.00% | — | 5.33M | — | 5.33M | IA | — | 2022-04-21 | ↗ |
| 3 | Perceptive Life Sciences Master Fund, Ltd. | 5.33M | 10.00% | — | 5.33M | — | 5.33M | CO | — | 2022-04-21 | ↗ |
| 4 | 52-0556948 | 4.94M | 6.20% | 4.85M | — | — | — | IA | Maryland | 2024-11-14 | ↗ |
| 5 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.79M | 10.09% | — | 4.79M | — | 4.79M | IA | Delaware USA | 2022-01-10 | ↗ |
| 6 | Wellington Group Holdings LLP | 4.46M | 5.57% | — | 3.67M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 7 | Wellington Investment Advisors Holdings LLP | 4.46M | 5.57% | — | 3.67M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 8 | Wellington Management Group LLP | 4.46M | 5.57% | — | 3.67M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 9 | Wellington Management Company LLP | 4.16M | 5.20% | — | 3.64M | — | — | IA | Massachusetts | 2024-11-08 | ↗ |
| 10 | EcoR1 Capital, LLC | 4.16M | 11.00% | — | 4.16M | — | 4.16M | IA, OO | Delaware | 2024-03-11 | ↗ |
| 11 | Oleg Nodelman | 4.16M | 11.00% | — | 4.16M | — | 4.16M | HC, IN | Delaware | 2024-03-11 | ↗ |
| 12 | Abigail P. Johnson | 4.04M | 6.05% | — | — | 4.04M | — | IN | United States of America | 2024-02-09 | ↗ |
| 13 | FMR LLC | 4.04M | 6.05% | 4.04M | — | 4.04M | — | HC | Delaware | 2024-02-09 | ↗ |
| 14 | EcoR1 Capital Fund Qualified, L.P. | 3.91M | 11.00% | — | 3.91M | — | 3.91M | PN | Delaware | 2024-03-11 | ↗ |
| 15 | 2 | 3.72M | 5.60% | — | 3.72M | — | — | CO | Delaware | 2023-09-18 | ↗ |
| 16 | STATE STREET CORPORATION | 3.56M | 5.34% | — | 3.42M | — | 3.56M | HC | BOSTON, MASSACHUSETTS | 2024-01-24 | ↗ |
| 17 | The Vanguard Group - 23-1945930 | 3.50M | 5.24% | — | — | — | 103.6K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 18 | ALEXANDER T. KARNAL | 3.47M | 6.45% | — | 3.47M | — | — | HC, IN | United States of America | 2023-02-14 | ↗ |
| 19 | BRAIDWELL LP | 3.47M | 6.45% | — | 3.47M | — | — | IA, PN | Delaware | 2023-02-14 | ↗ |
| 20 | BRAIDWELL MANAGEMENT LLC | 3.47M | 6.45% | — | 3.47M | — | — | HC, OO | Delaware | 2023-02-14 | ↗ |
| 21 | BRIAN J. KREITER | 3.47M | 6.45% | — | 3.47M | — | — | HC, OO | United States of America | 2023-02-14 | ↗ |
| 22 | (1) BlackRock, Inc. | 3.28M | 6.90% | 3.22M | — | 3.28M | — | HC | Delaware | 2022-02-03 | ↗ |
| 23 | OrbiMed Advisors LLC | 3.20M | 6.70% | — | 3.20M | — | — | IA | Delaware | 2022-02-11 | ↗ |
| 24 | BVF Partners L.P. | 3.00M | 6.50% | — | — | — | 3.00M | IA, PN | Delaware | 2021-10-29 | ↗ |
| 25 | BVF GP HOLDINGS LLC | 2.77M | 6.00% | — | — | — | 2.77M | OO | Delaware | 2021-10-29 | ↗ |
| 26 | OrbiMed Capital GP VI LLC | 2.71M | 5.70% | — | 2.71M | — | — | OO | Delaware | 2022-02-11 | ↗ |
| 27 | R. Scott Struthers | 1.98M | 4.20% | 1.98M | — | 1.98M | — | IN | United States | 2022-02-10 | ↗ |
| 28 | David Kroin | 1.90M | 4.00% | — | 1.90M | — | — | HC, IN | United States | 2022-02-14 | ↗ |
| 29 | Deep Track Biotechnology Master Fund, Ltd. | 1.90M | 4.00% | — | 1.90M | — | — | CO | Cayman Islands | 2022-02-14 | ↗ |
| 30 | Deep Track Capital, LP | 1.90M | 4.00% | — | 1.90M | — | — | IA, OO | Delaware | 2022-02-14 | ↗ |
| 31 | BVF I GP LLC | 1.60M | 3.50% | — | — | — | 1.60M | OO | Delaware | 2021-10-29 | ↗ |
| 32 | Biotechnology Value Fund, L.P. | 1.60M | 3.50% | — | — | — | 1.60M | PN | Delaware | 2021-10-29 | ↗ |
| 33 | BVF II GP LLC | 1.17M | 2.50% | — | — | — | 1.17M | OO | Delaware | 2021-10-29 | ↗ |
| 34 | Biotechnology Value Fund II, L.P. | 1.17M | 2.50% | — | — | — | 1.17M | PN | Delaware | 2021-10-29 | ↗ |
| 35 | Versant Ventures V, LLC | 383.0K | 0.80% | — | 383.0K | — | 383.0K | OO | — | 2022-02-11 | ↗ |
| 36 | Versant Venture Capital V, L.P. | 360.0K | 0.80% | 360.0K | — | 360.0K | — | PN | — | 2022-02-11 | ↗ |
| 37 | BVF Partners OS Ltd. | 178.7K | 1.00% | — | — | — | 178.7K | CO | Delaware | 2021-10-29 | ↗ |
| 38 | Biotechnology Value Trading Fund OS LP | 178.7K | 1.00% | — | — | — | 178.7K | PN | Delaware | 2021-10-29 | ↗ |
| 39 | GP-GP | 27.4K | 0.10% | — | 27.4K | — | 27.4K | CO | — | 2022-02-11 | ↗ |
| 40 | Versant Venture Capital V (Canada) LP | 27.4K | 0.10% | 27.4K | — | 27.4K | — | PN | — | 2022-02-11 | ↗ |
| 41 | Versant Ventures V (Canada), L.P. | 27.4K | 0.10% | — | 27.4K | — | 27.4K | PN | — | 2022-02-11 | ↗ |
| 42 | Versant Ophthalmic Affiliates Fund I, L.P. | 12.1K | 0.00% | 12.1K | — | 12.1K | — | PN | — | 2022-02-11 | ↗ |
| 43 | Versant Affiliates Fund V, L.P. | 10.8K | 0.00% | 10.8K | — | 10.8K | — | PN | — | 2022-02-11 | ↗ |
| 44 | Vivo Capital VIII, LLC | — | 0.00% | — | — | — | — | OO | Delaware | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
48
-202 vs prev Q
New positions
11
Closed positions
208
Increased
29
Reduced
11
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 224.1K +224.1K (+100.0%) | 10.43B +10.4B (+100.0%) | 0.24% +0.238 pp | 7.48% +7.480 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 14.29M +106.3K (+0.7%) | 665.38M +74.5M (+12.6%) | 15.17% +0.045 pp | 0.03% +0.003 pp | USD39.18 +18.8% | 30 qtrs — |
| 3 | VANGUARD GROUP INC | 9.14M -34.6K (-0.4%) | 425.26M +43.3M (+11.3%) | 9.70% -0.081 pp | 0.01% +0.000 pp | USD39.56 +17.7% | 30 qtrs — |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 8.04M -344.1K (-4.1%) | 374.16M +25.1M (+7.2%) | 8.53% -0.405 pp | 0.07% +0.005 pp | USD38.11 +22.1% | 23 qtrs — |
| 5 | BLACKROCK, INC. | 7.99M +402.0K (+5.3%) | 371.87M +55.9M (+17.7%) | 8.48% +0.390 pp | 0.01% +0.001 pp | USD50.37 -7.6% | 6 qtrs — |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | 6.93M +1.2M (+20.2%) | 322.74M +82.4M (+34.3%) | 7.36% +1.207 pp | 1.52% +0.539 pp | USD46.97 -0.9% | 10 qtrs — |
| 7 | DRIEHAUS CAPITAL MANAGEMENT LLC | 6.39M -93.9K (-1.4%) | 297.35M +27.4M (+10.1%) | 6.78% -0.131 pp | 2.02% +0.086 pp | USD26.87 +73.2% | 23 qtrs — |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.22M -81.9K (-1.5%) | 243.20M +22.2M (+10.0%) | 5.55% -0.112 pp | 0.03% +0.003 pp | USD34.83 +33.6% | 30 qtrs — |
| 9 | JANUS HENDERSON GROUP PLC | 4.44M +581.9K (+15.1%) | 206.60M +45.9M (+28.6%) | 4.71% +0.599 pp | 0.09% +0.019 pp | USD41.45 +12.3% | 14 qtrs — |
| 10 | ECOR1 CAPITAL, LLC | 4.29M +— (+0.0%) | 199.61M +21.0M (+11.8%) | 4.55% -0.021 pp | 9.06% +0.486 pp | USD37.51 +24.1% | 17 qtrs — |
| 11 | POINT72 ASSET MANAGEMENT, L.P. | 2.34M +333.7K (+16.7%) | 108.79M +25.4M (+30.4%) | 2.48% +0.345 pp | 0.12% -0.018 pp | USD34.33 +35.6% | 26 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.24M -36.2K (-1.6%) | 104.41M +9.5M (+10.0%) | 2.38% -0.049 pp | 0.01% +0.000 pp | USD32.96 +41.2% | 30 qtrs — |
| 13 | PARADIGM BIOCAPITAL ADVISORS LP | 2.21M -340.0K (-13.3%) | 102.91M -3.3M (-3.1%) | 2.35% -0.373 pp | 2.63% -0.395 pp | USD30.28 +53.7% | 14 qtrs — |
| 14 | STATE STREET CORP | 2.16M -46.3K (-2.1%) | 100.61M +8.7M (+9.4%) | 2.29% -0.060 pp | 0.00% +0.000 pp | USD27.51 +69.2% | 30 qtrs — |
| 15 | BAKER BROS. ADVISORS LP | 1.65M +1.4M (+488.9%) | 76.75M +65.1M (+558.2%) | 1.75% +1.452 pp | 0.45% +0.365 pp | USD43.53 +6.9% | 3 qtrs — |
| 16 | NOVO HOLDINGS A/S | 1.63M +— (+0.0%) | 75.64M +8.0M (+11.8%) | 1.72% -0.008 pp | 5.87% +1.512 pp | USD24.54 +89.7% | 16 qtrs — |
| 17 | PICTET ASSET MANAGEMENT HOLDING SA | 1.56M +95.0K (+6.5%) | 72.63M +11.6M (+19.0%) | 1.66% +0.094 pp | 0.07% +0.012 pp | USD43.84 +6.2% | 9 qtrs — |
| 18 | SIREN, L.L.C. | 1.51M -181.0K (-10.7%) | 70.18M -150.2K (-0.2%) | 1.60% -0.200 pp | 2.09% -0.658 pp | USD50.28 -7.4% | 6 qtrs — |
| 19 | GW&K INVESTMENT MANAGEMENT, LLC | 1.48M +625.8K (+73.6%) | 68.72M +33.3M (+94.0%) | 1.57% +0.660 pp | 0.59% +0.281 pp | USD38.74 +20.2% | 12 qtrs — |
| 20 | RTW INVESTMENTS, LP | 1.35M +478.9K (+54.9%) | 62.90M +26.6M (+73.1%) | 1.43% +0.504 pp | 0.63% +0.182 pp | USD38.93 +19.6% | 3 qtrs — |
| 21 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.33M +493.4K (+59.2%) | 61.79M +27.1M (+77.9%) | 1.41% +0.520 pp | 0.07% -0.019 pp | USD34.76 +33.9% | 14 qtrs — |
| 22 | JENNISON ASSOCIATES LLC | 1.28M -763.1K (-37.3%) | 59.66M -25.5M (-29.9%) | 1.36% -0.820 pp | 0.04% -0.014 pp | USD32.11 +45.0% | 11 qtrs — |
| 23 | FIRST LIGHT ASSET MANAGEMENT, LLC | 1.19M +252.7K (+26.8%) | 55.59M +16.4M (+41.8%) | 1.27% +0.264 pp | 4.25% +0.554 pp | USD29.73 +56.6% | 17 qtrs — |
| 24 | JPMORGAN CHASE & CO | 1.15M -104.0K (-8.3%) | 53.75M +1.3M (+2.5%) | 1.23% -0.116 pp | 0.00% +0.000 pp | USD41.03 +13.5% | 30 qtrs — |
| 25 | AMERICAN CENTURY COMPANIES INC | 1.07M -64.7K (-5.7%) | 49.76M +2.5M (+5.4%) | 1.13% -0.074 pp | 0.03% +0.001 pp | USD42.21 +10.3% | 11 qtrs — |
| 26 | ORBIMED ADVISORS LLC | 999.0K -100.0K (-9.1%) | 46.50M +730.1K (+1.6%) | 1.06% -0.111 pp | 0.95% -0.126 pp | USD23.70 +96.4% | 30 qtrs — |
| 27 | UBS GROUP AG | 908.2K +500.5K (+122.7%) | 42.28M +25.3M (+149.0%) | 0.96% +0.529 pp | 0.01% +0.004 pp | USD46.10 +1.0% | 30 qtrs — |
| 28 | HOOD RIVER CAPITAL MANAGEMENT LLC | 897.4K +14.4K (+1.6%) | 41.77M +5.0M (+13.6%) | 0.95% +0.011 pp | 0.46% +0.024 pp | USD47.94 -2.9% | 7 qtrs — |
| 29 | CANDRIAM S.C.A. | 831.0K +85.9K (+11.5%) | 38.68M +7.6M (+24.7%) | 0.88% +0.088 pp | 0.19% +0.030 pp | USD34.21 +36.1% | 4 qtrs — |
| 30 | BANK OF AMERICA CORP /DE/ | 801.3K +200.3K (+33.3%) | 37.30M +12.3M (+49.0%) | 0.85% +0.210 pp | 0.00% +0.001 pp | USD34.47 +35.0% | 30 qtrs — |
| 31 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 782.0K +3.3K (+0.4%) | 36.40M +4.0M (+12.2%) | 0.83% 0.000 pp | 0.01% +0.001 pp | USD33.35 +39.6% | 30 qtrs — |
| 32 | NORTHERN TRUST CORP | 769.8K -40.1K (-4.9%) | 35.84M +2.1M (+6.2%) | 0.82% -0.046 pp | 0.00% +0.000 pp | USD31.88 +46.0% | 30 qtrs — |
| 33 | MORGAN STANLEY | 768.8K +86.7K (+12.7%) | 35.79M +7.4M (+26.0%) | 0.82% +0.089 pp | 0.00% +0.000 pp | USD30.15 +54.4% | 30 qtrs — |
| 34 | FISHER ASSET MANAGEMENT, LLC | 758.7K +302.0 (+0.0%) | 35.32M +3.7M (+11.8%) | 0.81% -0.003 pp | 0.01% +0.001 pp | USD36.46 +27.7% | 14 qtrs — |
| 35 | ABRDN PLC | 674.5K +334.6K (+98.4%) | 31.40M +17.2M (+121.8%) | 0.72% +0.354 pp | 0.05% +0.026 pp | USD40.51 +14.9% | 9 qtrs — |
| 36 | AMERIPRISE FINANCIAL INC | 601.2K -13.6K (-2.2%) | 27.99M +2.4M (+9.3%) | 0.64% -0.017 pp | 0.01% +0.000 pp | USD43.99 +5.8% | 7 qtrs — |
| 37 | FIERA CAPITAL CORP | 578.5K +143.0K (+32.8%) | 26.93M +8.8M (+48.5%) | 0.61% +0.150 pp | 0.09% +0.027 pp | USD46.35 +0.4% | 8 qtrs — |
| 38 | GOLDMAN SACHS GROUP INC | 567.1K -146.0K (-20.5%) | 26.40M -3.3M (-11.1%) | 0.60% -0.158 pp | 0.00% 0.000 pp | USD29.86 +55.9% | 23 qtrs — |
| 39 | DIMENSIONAL FUND ADVISORS LP | 549.0K +171.2K (+45.3%) | 25.56M +9.8M (+62.4%) | 0.58% +0.180 pp | 0.01% +0.002 pp | USD39.23 +18.7% | 21 qtrs — |
| 40 | NUVEEN, LLC | 522.5K -22.3K (-4.1%) | 24.32M +1.6M (+7.2%) | 0.55% -0.026 pp | 0.01% +0.000 pp | USD33.83 +37.6% | 4 qtrs — |
| 41 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 408.3K +20.4K (+5.3%) | 19.01M +2.8M (+17.6%) | 0.43% +0.020 pp | 0.03% +0.004 pp | USD49.49 -5.9% | 5 qtrs — |
| 42 | BANK OF NEW YORK MELLON CORP | 405.0K +5.4K (+1.3%) | 18.85M +2.2M (+13.3%) | 0.43% +0.004 pp | 0.00% +0.000 pp | USD29.62 +57.2% | 30 qtrs — |
| 43 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 398.4K +154.5K (+63.3%) | 18.55M +8.4M (+82.6%) | 0.42% +0.163 pp | 0.00% +0.001 pp | USD43.55 +6.9% | 2 qtrs — |
| 44 | IKARIAN CAPITAL, LLC | 368.5K +368.5K (+100.0%) | 17.15M +17.2M (+100.0%) | 0.39% +0.391 pp | 1.34% +1.339 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 45 | ADAR1 CAPITAL MANAGEMENT, LLC | 309.4K +61.0K (+24.6%) | 14.40M +4.1M (+39.2%) | 0.33% +0.064 pp | 1.06% +0.086 pp | USD43.51 +7.0% | 7 qtrs — |
| 46 | VOYA INVESTMENT MANAGEMENT LLC | 302.0K +267.3K (+770.5%) | 14.06M +12.6M (+872.9%) | 0.32% +0.284 pp | 0.01% +0.012 pp | USD46.41 +0.3% | 21 qtrs — |
| 47 | MILLENNIUM MANAGEMENT LLC | 300.3K +84.1K (+38.9%) | 13.98M +5.0M (+55.2%) | 0.32% +0.088 pp | 0.01% +0.002 pp | USD33.81 +37.7% | 4 qtrs — |
| 48 | CORMORANT ASSET MANAGEMENT, LP | 300.0K -100.0K (-25.0%) | 13.97M -2.7M (-16.2%) | 0.32% -0.108 pp | 0.65% -0.504 pp | USD32.37 +43.8% | 10 qtrs — |
| 49 | ENSIGN PEAK ADVISORS, INC | 275.6K -19.4K (-6.6%) | 12.83M +542.8K (+4.4%) | 0.29% -0.022 pp | 0.02% +0.003 pp | USD30.84 +50.9% | 18 qtrs — |
| 50 | IMPAX ASSET MANAGEMENT GROUP PLC | 275.0K +275.0K (+100.0%) | 12.80M +12.8M (+100.0%) | 0.29% +0.292 pp | 0.08% +0.080 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 51 | PROSIGHT MANAGEMENT, LP | 262.9K -65.8K (-20.0%) | 12.24M -1.5M (-10.6%) | 0.28% -0.071 pp | 2.53% -0.664 pp | USD29.96 +55.4% | 3 qtrs — |
| 52 | CITADEL ADVISORS LLC | 254.7K -629.8K (-71.2%) | 11.86M -25.0M (-67.8%) | 0.27% -0.673 pp | 0.00% -0.004 pp | USD32.39 +43.7% | 27 qtrs — |
| 53 | DEUTSCHE BANK AG\ | 235.0K +2.7K (+1.1%) | 10.94M +1.3M (+13.0%) | 0.25% +0.002 pp | 0.00% +0.000 pp | USD41.21 +13.0% | 30 qtrs — |
| 54 | BALYASNY ASSET MANAGEMENT L.P. | 233.2K +219.2K (+1,560.4%) | 10.86M +10.3M (+1,755.7%) | 0.25% +0.233 pp | 0.01% +0.013 pp | USD46.25 +0.6% | 2 qtrs — |
| 55 | UBS ASSET MANAGEMENT AMERICAS INC | 225.8K +8.2K (+3.7%) | 10.51M +1.4M (+16.0%) | 0.24% +0.008 pp | 0.00% +0.000 pp | USD43.18 +7.8% | 23 qtrs — |
| 56 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 213.9K +35.3K (+19.8%) | 9.96M +2.5M (+33.9%) | 0.23% +0.037 pp | 0.04% +0.010 pp | USD43.26 +7.6% | 5 qtrs — |
| 57 | SCHRODER INVESTMENT MANAGEMENT GROUP | 187.4K +100.1K (+114.7%) | 8.88M +5.1M (+133.8%) | 0.20% +0.106 pp | 0.01% +0.004 pp | USD41.19 +13.0% | 5 qtrs — |
| 58 | TD ASSET MANAGEMENT INC | 190.5K -13.1K (-6.4%) | 8.87M +389.0K (+4.6%) | 0.20% -0.015 pp | 0.01% +0.000 pp | USD33.09 +40.7% | 12 qtrs — |
| 59 | SEGALL BRYANT & HAMILL, LLC | 189.5K +8.6K (+4.8%) | 8.82M +1.3M (+17.1%) | 0.20% +0.008 pp | 0.12% +0.019 pp | USD47.13 -1.2% | 5 qtrs — |
| 60 | BARCLAYS PLC | 185.7K -22.0K (-10.6%) | 8.64M -2.0M (-18.6%) | 0.20% -0.024 pp | 0.00% -0.001 pp | USD35.83 +29.9% | 30 qtrs — |
| 61 | NEUBERGER BERMAN GROUP LLC | 182.2K +115.0K (+171.3%) | 8.48M +5.7M (+203.2%) | 0.19% +0.122 pp | 0.01% +0.004 pp | USD44.74 +4.0% | 2 qtrs — |
| 62 | SWISS NATIONAL BANK | 176.5K +4.0K (+2.3%) | 8.22M +1.0M (+14.4%) | 0.19% +0.003 pp | 0.00% +0.001 pp | USD33.22 +40.1% | 27 qtrs — |
| 63 | RICE HALL JAMES & ASSOCIATES, LLC | 171.8K -2.2K (-1.3%) | 8.00M +748.4K (+10.3%) | 0.18% -0.003 pp | 0.44% +0.045 pp | USD41.65 +11.8% | 2 qtrs — |
| 64 | INVESCO LTD. | 158.1K +68.7K (+76.8%) | 7.36M +3.6M (+97.7%) | 0.17% +0.073 pp | 0.00% +0.001 pp | USD41.32 +12.7% | 19 qtrs — |
| 65 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 148.5K +676.0 (+0.5%) | 7.00M +845.9K (+13.7%) | 0.16% +0.000 pp | 0.01% +0.001 pp | USD33.90 +37.3% | 23 qtrs — |
| 66 | NEW YORK STATE COMMON RETIREMENT FUND | 146.1K -2.2K (-1.5%) | 6.80M +626.3K (+10.1%) | 0.16% -0.003 pp | 0.01% +0.001 pp | USD42.60 +9.3% | 29 qtrs — |
| 67 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 144.2K +144.2K (+100.0%) | 6.71M +6.7M (+100.0%) | 0.15% +0.153 pp | 0.05% +0.046 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 68 | WELLS FARGO & COMPANY/MN | 139.5K +40.8K (+41.3%) | 6.49M +2.4M (+57.9%) | 0.15% +0.043 pp | 0.00% +0.000 pp | USD43.31 +7.5% | 17 qtrs — |
| 69 | VICTORY CAPITAL MANAGEMENT INC | 138.7K -94.7K (-40.6%) | 6.46M -3.3M (-33.6%) | 0.15% -0.102 pp | 0.00% -0.002 pp | USD41.71 +11.6% | 10 qtrs — |
| 70 | ENVESTNET ASSET MANAGEMENT INC | 130.4K +77.7K (+147.5%) | 6.07M +3.9M (+176.7%) | 0.14% +0.082 pp | 0.00% +0.001 pp | USD46.84 -0.6% | 8 qtrs — |
| 71 | SIO CAPITAL MANAGEMENT, LLC | 124.8K -50.0K (-28.6%) | 5.81M -1.5M (-20.2%) | 0.13% -0.054 pp | 0.91% -0.929 pp | USD41.65 +11.8% | 2 qtrs — |
| 72 | RUSSELL INVESTMENTS GROUP, LTD. | 119.9K -29.1K (-19.5%) | 5.58M -623.4K (-10.0%) | 0.13% -0.032 pp | 0.01% -0.001 pp | USD36.16 +28.7% | 10 qtrs — |
| 73 | RHUMBLINE ADVISERS | 115.8K -15.8K (-12.0%) | 5.39M -89.6K (-1.6%) | 0.12% -0.017 pp | 0.00% +0.000 pp | USD26.94 +72.8% | 29 qtrs — |
| 74 | SECTOR GAMMA AS | 115.0K +115.0K (+100.0%) | 5.35M +5.4M (+100.0%) | 0.12% +0.122 pp | 1.22% +1.220 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 75 | BOOTHBAY FUND MANAGEMENT, LLC | 114.7K +114.7K (+100.0%) | 5.34M +5.3M (+100.0%) | 0.12% +0.122 pp | 0.08% +0.080 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 76 | MOODY ALDRICH PARTNERS LLC | 110.4K -5.1K (-4.4%) | 5.14M +327.5K (+6.8%) | 0.12% -0.006 pp | 0.96% +0.046 pp | USD46.42 +0.3% | 10 qtrs — |
| 77 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 100.6K +88.0K (+701.7%) | 4.68M +4.2M (+796.0%) | 0.11% +0.093 pp | 0.01% +0.011 pp | USD45.94 +1.3% | 2 qtrs — |
| 78 | AWM INVESTMENT COMPANY, INC. | 100.0K +— (+0.0%) | 4.66M +490.0K (+11.8%) | 0.11% -0.001 pp | 0.45% +0.059 pp | USD34.74 +34.0% | 10 qtrs — |
| 79 | ALLIANCEBERNSTEIN L.P. | 93.0K +— (+0.0%) | 4.33M +455.8K (+11.8%) | 0.10% 0.000 pp | 0.00% +0.000 pp | USD30.92 +50.5% | 27 qtrs — |
| 80 | DECHENG CAPITAL LLC | 92.7K -50.3K (-35.2%) | 4.32M -1.6M (-27.5%) | 0.10% -0.054 pp | 0.58% -0.459 pp | USD46.06 +1.1% | 8 qtrs — |
| 81 | LEGAL & GENERAL GROUP PLC | 87.8K -6.0K (-6.4%) | 4.09M +180.0K (+4.6%) | 0.09% -0.007 pp | 0.00% +0.000 pp | USD32.65 +42.6% | 30 qtrs — |
| 82 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 85.6K +1.4K (+1.7%) | 3.98M +477.1K (+13.6%) | 0.09% +0.001 pp | 0.00% +0.000 pp | USD31.55 +47.5% | 30 qtrs — |
| 83 | ALPS ADVISORS INC | 77.8K +30.4K (+64.0%) | 3.62M +1.6M (+83.3%) | 0.08% +0.032 pp | 0.02% +0.010 pp | USD38.44 +21.1% | 27 qtrs — |
| 84 | CAPTION MANAGEMENT, LLC | 75.1K -113.1K (-60.1%) | 3.50M -4.3M (-55.4%) | 0.08% -0.121 pp | 0.02% -0.037 pp | USD40.28 +15.6% | 3 qtrs — |
| 85 | AFFINITY ASSET ADVISORS, LLC | 75.0K +— (+0.0%) | 3.49M +367.5K (+11.8%) | 0.08% 0.000 pp | 0.20% -0.073 pp | USD34.42 +35.2% | 10 qtrs — |
| 86 | SEI INVESTMENTS CO | 72.0K +11.7K (+19.4%) | 3.35M +840.6K (+33.4%) | 0.08% +0.012 pp | 0.00% +0.001 pp | USD42.48 +9.6% | 10 qtrs — |
| 87 | CASTLEARK MANAGEMENT LLC | 62.8K +62.8K (+100.0%) | 2.92M +2.9M (+100.0%) | 0.07% +0.067 pp | 0.09% +0.086 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 88 | MAN GROUP PLC | 62.6K +62.6K (+100.0%) | 2.91M +2.9M (+100.0%) | 0.07% +0.066 pp | 0.01% +0.005 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 89 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 59.1K -1.5K (-2.4%) | 2.75M +229.0K (+9.1%) | 0.06% -0.002 pp | 0.00% +0.000 pp | USD28.04 +66.0% | 12 qtrs — |
| 90 | STATE OF WISCONSIN INVESTMENT BOARD | 55.6K -1.5K (-2.6%) | 2.59M +211.3K (+8.9%) | 0.06% -0.002 pp | 0.01% +0.000 pp | USD33.11 +40.6% | 29 qtrs — |
| 91 | PHOCAS FINANCIAL CORP. | 53.9K -138.0 (-0.3%) | 2.51M +258.2K (+11.5%) | 0.06% 0.000 pp | 0.33% +0.035 pp | USD41.65 +11.8% | 2 qtrs — |
| 92 | WALLEYE TRADING LLC | 50.6K +50.6K (+100.0%) | 2.36M +2.4M (+100.0%) | 0.05% +0.054 pp | 0.00% +0.003 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 93 | METLIFE INVESTMENT MANAGEMENT, LLC | 49.8K -3.6K (-6.7%) | 2.32M +94.3K (+4.2%) | 0.05% -0.004 pp | 0.01% +0.001 pp | USD32.48 +43.3% | 27 qtrs — |
| 94 | TWO SIGMA INVESTMENTS, LP | 49.7K +— (+0.0%) | 2.31M +243.5K (+11.8%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD28.76 +61.9% | 3 qtrs — |
| 95 | CREATIVE PLANNING | 47.3K +6.7K (+16.6%) | 2.20M +513.0K (+30.4%) | 0.05% +0.007 pp | 0.00% +0.000 pp | USD45.74 +1.8% | 8 qtrs — |
| 96 | ROYAL BANK OF CANADA | 47.3K -123.2K (-72.3%) | 2.20M -4.9M (-69.0%) | 0.05% -0.132 pp | 0.00% -0.001 pp | USD30.00 +55.2% | 30 qtrs — |
| 97 | VESTMARK ADVISORY SOLUTIONS, INC. | 46.6K +46.6K (+100.0%) | 2.17M +2.2M (+100.0%) | 0.05% +0.049 pp | 0.03% +0.029 pp | USD46.55 +0.0% | 1 qtrs NEW |
| 98 | LISANTI CAPITAL GROWTH, LLC | 43.0K +20.2K (+88.0%) | 2.00M +1.1M (+110.2%) | 0.05% +0.021 pp | 0.47% +0.242 pp | USD43.94 +5.9% | 2 qtrs — |
| 99 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 42.0K -7.0 (0.0%) | 1.96M +205.5K (+11.7%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD46.03 +1.1% | 7 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.75
Neutral
Ratio by volume
0.48
Bearish
Buys
3
Sells
4
Shares acquired
78.4K
Shares disposed
163.6K
Cash buys
—
Cash sales
1.00
Net activity
-85,163
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | Knight Jeff E. | Officer | M-Exempt | A | Common Stock | 19,336 | 19.64 | 379.8K | 190,452 | D | ↗ |
| 2026-03-16 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 13,196 | 37.11 | 489.7K | 413,563 | D | ↗ |
| 2026-03-16 | Knight Jeff E. | Officer | S-Sale | D | Common Stock | 5,950 | 37.11 | 220.8K | 115,979 | D | ↗ |
| 2026-03-16 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 6,371 | 37.11 | 236.4K | 141,342 | D | ↗ |
| 2026-03-12 | Vivaldi Coelho Rogerio | Director | S-Sale | D | Common Stock | 4,477 | 36.08 | 161.5K | 16,823 | D | ↗ |
| 2026-03-03 | Schilke Tobin | Officer | S-Sale | D | Common Stock | 6,713 | 39.67 | 266.3K | 78,121 | D | ↗ |
| 2026-03-03 | Okey Stephanie | Director | S-Sale | D | Common Stock | 3,000 | 39.67 | 119.0K | 13,300 | D | ↗ |
| 2026-02-23 | Struthers Richard Scott | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 228,000 | 43.79 | 9.98M | 228,000 | D | ↗ |
| 2026-02-23 | Schilke Tobin | Officer | A-Award | A | Common Stock | 32,000 | 0.00 | — | 84,834 | D | ↗ |
| 2026-02-23 | Knight Jeff E. | Officer | A-Award | A | Common Stock | 34,000 | 0.00 | — | 121,929 | D | ↗ |
| 2026-02-23 | Kalofonos Isabel | Officer | A-Award | A | Stock Option (Right to Buy) | 55,000 | 43.79 | 2.41M | 55,000 | D | ↗ |
| 2026-02-23 | Betz Stephen F. | Officer | A-Award | A | Stock Option (Right to Buy) | 47,000 | 43.79 | 2.06M | 47,000 | D | ↗ |
| 2026-01-05 | Kalofonos Isabel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,500 | 40.59 | 101.5K | 97,500 | D | ↗ |
| 2025-12-26 | Betz Stephen F. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 18,000 | 1.91 | 34.4K | 90,514 | D | ↗ |
| 2025-12-18 | Struthers Richard Scott | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 28,400 | 15.29 | 434.2K | 259,058 | D | ↗ |
| 2025-12-01 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 5,000 | 16.89 | 84.5K | 71,837 | D | ↗ |
| 2025-11-03 | Pizzuti Dana | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 16.89 | 84.5K | 74,042 | D | ↗ |
| 2025-10-01 | Pizzuti Dana | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 16.89 | 84.5K | 79,042 | D | ↗ |
| 2025-09-26 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 4,000 | 45.00 | 180.0K | 106,000 | I | ↗ |
| 2025-09-26 | Fust Matthew K | Director | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 1.91 | 19.1K | 2,092 | D | ↗ |
| 2025-09-02 | Pizzuti Dana | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 16.89 | 84.5K | 84,042 | D | ↗ |
| 2025-08-22 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 30,000 | 16.89 | 506.7K | 96,270 | D | ↗ |
| 2025-08-20 | Pizzuti Dana | Officer | S-Sale | D | Common Stock | 6,492 | 29.18 | 189.4K | 66,270 | D | ↗ |
| 2025-06-12 | Betz Stephen F. | Officer | M-Exempt | A | Common Stock | 16,645 | 9.28 | 154.5K | 197,196 | D | ↗ |
| 2025-06-11 | WIERENGA WENDALL | Director | A-Award | A | Common Stock | 6,900 | 0.00 | — | 116,146 | D | ↗ |
| 2025-06-11 | Vivaldi Coelho Rogerio | Director | A-Award | A | Stock Option (right to buy) | 10,350 | 32.33 | 334.6K | 10,350 | D | ↗ |
| 2025-06-11 | Okey Stephanie | Director | A-Award | A | Stock Option (right to buy) | 10,350 | 32.33 | 334.6K | 10,350 | D | ↗ |
| 2025-06-11 | Nichols Weston | Director | A-Award | A | Common Stock | 6,900 | 0.00 | — | 16,300 | D | ↗ |
| 2025-06-11 | Fust Matthew K | Director | A-Award | A | Common Stock | 6,900 | 0.00 | — | 28,836 | D | ↗ |
| 2025-06-11 | Deardorf Caren | Director | A-Award | A | Stock Option (right to buy) | 10,350 | 32.33 | 334.6K | 10,350 | D | ↗ |
| 2025-06-11 | Bedrosian Camille L | Director | A-Award | A | Common Stock | 6,900 | 0.00 | — | 16,300 | D | ↗ |
| 2025-05-14 | Struthers Richard Scott | Director / Officer | G-Gift | A | Common Stock | 90,400 | 0.00 | — | 661,205 | I | ↗ |
| 2025-04-02 | Struthers Richard Scott | Director / Officer | M-Exempt | A | Common Stock | 81,270 | 1.91 | 155.2K | 410,417 | D | ↗ |
| 2025-03-19 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 16,463 | 34.17 | 562.5K | 330,022 | D | ↗ |
| 2025-03-19 | Pizzuti Dana | Officer | S-Sale | D | Common Stock | 127 | 34.83 | 4.4K | 72,233 | D | ↗ |
| 2025-03-19 | Knight Jeff E. | Officer | S-Sale | D | Common Stock | 361 | 34.83 | 12.6K | 87,491 | D | ↗ |
| 2025-03-19 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 291 | 34.83 | 10.1K | 108,588 | D | ↗ |
| 2025-03-10 | Schilke Tobin | Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 33.75 | 2.70M | 80,000 | D | ↗ |
| 2025-02-28 | Schilke Tobin | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-20 | Struthers Richard Scott | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 313,000 | 36.86 | 11.54M | 313,000 | D | ↗ |
| 2025-02-20 | Pizzuti Dana | Officer | A-Award | A | Stock Option (Right to Buy) | 65,000 | 36.86 | 2.40M | 65,000 | D | ↗ |
| 2025-02-20 | Knight Jeff E. | Officer | A-Award | A | Stock Option (Right to Buy) | 65,000 | 36.86 | 2.40M | 65,000 | D | ↗ |
| 2025-02-20 | Betz Stephen F. | Officer | A-Award | A | Stock Option (Right to Buy) | 65,000 | 36.86 | 2.40M | 65,000 | D | ↗ |
| 2025-02-03 | Pizzuti Dana | Officer | M-Exempt | D | Stock option (Right to Buy) | 5,000 | 16.89 | 84.5K | 119,042 | D | ↗ |
| 2025-01-10 | Kalofonos Isabel | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 40.59 | 4.06M | 100,000 | D | ↗ |
| 2025-01-07 | Pizzuti Dana | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,500 | 19.64 | 49.1K | 18,500 | D | ↗ |
| 2025-01-03 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 15,000 | 16.89 | 253.4K | 44,248 | D | ↗ |
| 2024-12-31 | Wilson Marc | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Betz Stephen F. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-16 | Kalofonos Isabel | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-16 | Betz Stephen F. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,331 | 1.91 | 4.5K | 180,039 | D | ↗ |
| 2024-12-02 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 10,000 | 57.57 | 575.7K | 100,000 | I | ↗ |
| 2024-11-22 | Knight Jeff E. | Officer | S-Sale | D | Common Stock | 501 | 56.52 | 28.3K | 51,653 | D | ↗ |
| 2024-10-03 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 14,375 | 16.89 | 242.8K | 42,882 | D | ↗ |
| 2024-09-26 | Wilson Marc | Officer | M-Exempt | A | Common Stock | 25,000 | 15.29 | 382.3K | 136,092 | D | ↗ |
| 2024-09-10 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 1,035 | 51.50 | 53.3K | 68,576 | — | ↗ |
| 2024-08-26 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 53.19 | 159.6K | 69,611 | — | ↗ |
| 2024-08-12 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 47.68 | 143.0K | 72,611 | — | ↗ |
| 2024-07-25 | Wilson Marc | Officer | M-Exempt | A | Common Stock | 19,056 | 9.28 | 176.8K | 130,148 | — | ↗ |
| 2024-07-25 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 53.43 | 160.3K | 75,611 | — | ↗ |
| 2024-07-15 | Wilson Marc | Officer | S-Sale | D | Common Stock | 25,000 | 55.00 | 1.38M | 111,092 | — | ↗ |
| 2024-07-15 | Knight Jeff E. | Officer | M-Exempt | A | Common Stock | 17,499 | 23.98 | 419.6K | 70,079 | — | ↗ |
| 2024-07-10 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 48.55 | 145.7K | 78,611 | — | ↗ |
| 2024-07-05 | Hassard James | Officer | M-Exempt | D | Stock option (Right to Buy) | 15,000 | 19.73 | 296.0K | 130,000 | — | ↗ |
| 2024-07-03 | Pizzuti Dana | Officer | M-Exempt | D | Stock option (Right to Buy) | 14,375 | 16.89 | 242.8K | 153,417 | — | ↗ |
| 2024-06-28 | Wilson Marc | Officer | M-Exempt | A | Common Stock | 32,129 | 9.28 | 298.2K | 143,221 | — | ↗ |
| 2024-06-26 | Knight Jeff E. | Officer | S-Sale | D | Common Stock | 956 | 44.38 | 42.4K | 52,580 | — | ↗ |
| 2024-06-25 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 45.37 | 136.1K | 80,643 | — | ↗ |
| 2024-06-24 | Pizzuti Dana | Officer | M-Exempt | D | Stock option (Right to Buy) | 9,500 | 19.73 | 187.4K | 167,792 | — | ↗ |
| 2024-06-21 | Hassard James | Officer | M-Exempt | D | Stock option (Right to Buy) | 15,000 | 19.73 | 296.0K | 145,000 | — | ↗ |
| 2024-06-10 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 43.86 | 131.6K | 83,643 | — | ↗ |
| 2024-06-07 | WIERENGA WENDALL | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 44.71 | 558.9K | 12,500 | — | ↗ |
| 2024-06-07 | Vivaldi Coelho Rogerio | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 44.71 | 558.9K | 12,500 | — | ↗ |
| 2024-06-07 | Okey Stephanie | Director | A-Award | A | Common Stock | 3,400 | 0.00 | — | 9,400 | — | ↗ |
| 2024-06-07 | Nichols Weston | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 44.71 | 558.9K | 12,500 | — | ↗ |
| 2024-06-07 | Fust Matthew K | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 44.71 | 558.9K | 12,500 | — | ↗ |
| 2024-06-07 | Deardorf Caren | Director | A-Award | A | Common Stock | 3,400 | 0.00 | — | 9,400 | — | ↗ |
| 2024-06-07 | Bedrosian Camille L | Director | A-Award | A | Common Stock | 3,400 | 0.00 | — | 9,400 | — | ↗ |
| 2024-05-28 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 47.49 | 142.5K | 86,643 | — | ↗ |
| 2024-05-10 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 49.43 | 148.3K | 89,643 | — | ↗ |
| 2024-05-08 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 107,448 | 49.40 | 5.31M | 257,485 | — | ↗ |
| 2024-04-18 | Struthers Richard Scott | Director / Officer | G-Gift | D | Common Stock | 350 | 0.00 | — | 257,485 | — | ↗ |
| 2024-04-15 | Struthers Richard Scott | Director / Officer | M-Exempt | A | Common Stock | 20,000 | 1.91 | 38.2K | 257,835 | — | ↗ |
| 2024-04-15 | Pizzuti Dana | Officer | M-Exempt | D | Stock option (Right to Buy) | 14,375 | 16.89 | 242.8K | 177,292 | — | ↗ |
| 2024-04-04 | Struthers Richard Scott | Director / Officer | M-Exempt | A | Common Stock | 40,951 | 9.28 | 380.0K | 278,786 | — | ↗ |
| 2024-03-28 | Okey Stephanie | Director | S-Sale | D | Common Stock | 17,500 | 46.38 | 811.7K | 6,000 | — | ↗ |
| 2024-03-22 | Knight Jeff E. | Officer | M-Exempt | A | Common Stock | 30,000 | 23.98 | 719.4K | 84,939 | — | ↗ |
| 2024-03-20 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 4,375 | 16.89 | 73.9K | 32,875 | — | ↗ |
| 2024-03-20 | Fust Matthew K | Director | S-Sale | D | Common Stock | 12,500 | 43.57 | 544.6K | 18,536 | — | ↗ |
| 2024-03-19 | Wilson Marc | Officer | S-Sale | D | Common Stock | 6,942 | 42.91 | 297.9K | 110,630 | — | ↗ |
| 2024-03-18 | Wilson Marc | Officer | F-InKind | D | Common Stock | 3,983 | 38.14 | 151.9K | 117,572 | — | ↗ |
| 2024-03-18 | Struthers Richard Scott | Director / Officer | F-InKind | D | Common Stock | 12,687 | 38.14 | 483.9K | 237,835 | — | ↗ |
| 2024-03-18 | Pizzuti Dana | Officer | F-InKind | D | Common Stock | 411 | 38.14 | 15.7K | 28,500 | — | ↗ |
| 2024-03-18 | Knight Jeff E. | Officer | F-InKind | D | Common Stock | 4,283 | 38.14 | 163.4K | 54,939 | — | ↗ |
| 2024-03-18 | Hassard James | Officer | F-InKind | D | Common Stock | 1,741 | 38.14 | 66.4K | 29,259 | — | ↗ |
| 2024-03-18 | Betz Stephen F. | Officer | F-InKind | D | Common Stock | 3,655 | 38.14 | 139.4K | 92,643 | — | ↗ |
| 2024-03-04 | Wilson Marc | Officer | A-Award | A | Stock Option (right to buy) | 95,500 | 43.51 | 4.16M | 95,500 | — | ↗ |
| 2024-03-04 | Struthers Richard Scott | Director / Officer | A-Award | A | Common Stock | 65,000 | 0.00 | — | 250,522 | — | ↗ |
| 2024-03-04 | Pizzuti Dana | Officer | A-Award | A | Stock Option (right to buy) | 87,000 | 43.51 | 3.79M | 87,000 | — | ↗ |
| 2024-03-04 | Knight Jeff E. | Officer | A-Award | A | Common Stock | 23,000 | 0.00 | — | 59,222 | — | ↗ |
| 2024-03-04 | Hassard James | Officer | A-Award | A | Common Stock | 17,000 | 0.00 | — | 31,000 | — | ↗ |
| 2024-03-04 | Betz Stephen F. | Officer | A-Award | A | Common Stock | 23,000 | 0.00 | — | 96,298 | — | ↗ |
| 2024-02-12 | Struthers Richard Scott | Director / Officer | G-Gift | D | Common Stock | 60,000 | 0.00 | — | 570,805 | — | ↗ |
| 2024-01-25 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 37.26 | 111.8K | 73,298 | — | ↗ |
| 2024-01-10 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 37.65 | 113.0K | 76,298 | — | ↗ |
| 2024-01-03 | Pizzuti Dana | Officer | M-Exempt | D | Non-qualified stock option (Right to Buy) | 14,375 | 16.89 | 242.8K | 206,042 | — | ↗ |
| 2024-01-02 | Wilson Marc | Officer | M-Exempt | D | Non-qualified stock option (Right to Buy) | 10,000 | 9.28 | 92.8K | 51,185 | — | ↗ |
| 2023-12-31 | Knight Jeff E. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-26 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 35.89 | 107.7K | 79,298 | — | ↗ |
| 2023-12-21 | Pizzuti Dana | Officer | M-Exempt | A | Common Stock | 9,583 | 16.89 | 161.9K | 15,494 | — | ↗ |
| 2023-12-11 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 32.87 | 98.6K | 82,298 | — | ↗ |
| 2023-11-27 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,000 | 31.84 | 95.5K | 85,298 | — | ↗ |
| 2023-11-09 | Struthers Richard Scott | Director / Officer | M-Exempt | A | Common Stock | 50,000 | 1.91 | 95.5K | 185,522 | — | ↗ |
| 2023-11-03 | Struthers Richard Scott | Director / Officer | M-Exempt | A | Common Stock | 199,082 | 9.28 | 1.85M | 334,604 | — | ↗ |
| 2023-11-02 | Struthers Richard Scott | Director / Officer | M-Exempt | D | Non-qualified stock option (Right to Buy) | 918 | 9.28 | 8.5K | 363,823 | — | ↗ |
| 2023-11-01 | Wilson Marc | Officer | S-Sale | D | Common Stock | 10,000 | 28.75 | 287.5K | 95,601 | — | ↗ |
| 2023-10-17 | Krasner Alan Seth | Officer | S-Sale | D | Common Stock | 7,000 | 30.00 | 210.0K | 43,210 | — | ↗ |
| 2023-08-14 | Struthers Richard Scott | Director / Officer | M-Exempt | D | Incentve stock option (Right to Buy) | 10,000 | 1.91 | 19.1K | 151,270 | — | ↗ |
| 2023-07-13 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 14,157 | 20.35 | 288.1K | 630,805 | — | ↗ |
| 2023-07-12 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 11,459 | 20.17 | 231.1K | 644,962 | — | ↗ |
| 2023-07-11 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 24,384 | 20.14 | 491.1K | 656,421 | — | ↗ |
| 2023-06-20 | Wilson Marc | Officer | S-Sale | D | Common Stock | 20,000 | 19.97 | 399.4K | 95,158 | — | ↗ |
| 2023-06-16 | WIERENGA WENDALL | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 20.32 | 355.6K | 17,500 | — | ↗ |
| 2023-06-16 | Vivaldi Coelho Rogerio | Director | A-Award | A | Common Stock | 6,000 | 0.00 | — | 11,000 | — | ↗ |
| 2023-06-16 | Struthers Richard Scott | Director / Officer | S-Sale | D | Common Stock | 50,000 | 20.81 | 1.04M | 680,805 | — | ↗ |
| 2023-06-16 | Okey Stephanie | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 20.32 | 355.6K | 17,500 | — | ↗ |
| 2023-06-16 | Nichols Weston | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 20.32 | 355.6K | 17,500 | — | ↗ |
| 2023-06-16 | Fust Matthew K | Director | A-Award | A | Common Stock | 6,000 | 0.00 | — | 18,536 | — | ↗ |
| 2023-06-16 | Deardorf Caren | Director | A-Award | A | Common Stock | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2023-06-16 | Bedrosian Camille L | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 20.32 | 355.6K | 17,500 | — | ↗ |
| 2023-06-08 | Vivaldi Coelho Rogerio | Director | P-Purchase | A | Common Stock | 5,000 | 22.06 | 110.3K | 5,000 | — | ↗ |
| 2023-04-05 | Pizzuti Dana | Officer | S-Sale | D | Common Stock | 8,212 | 16.15 | 132.6K | 4,500 | — | ↗ |
| 2023-04-03 | Pizzuti Dana | Officer | F-InKind | D | Common Stock | 4,288 | 15.98 | 68.5K | 12,712 | — | ↗ |
| 2023-03-16 | Wilson Marc | Officer | F-InKind | D | Common Stock | 1,666 | 17.12 | 28.5K | 106,080 | — | ↗ |
| 2023-03-16 | Struthers Richard Scott | Director / Officer | F-InKind | D | Common Stock | 4,628 | 17.12 | 79.2K | 125,522 | — | ↗ |
| 2023-03-16 | Krasner Alan Seth | Officer | F-InKind | D | Common Stock | 1,687 | 17.12 | 28.9K | 42,301 | — | ↗ |
| 2023-03-16 | Knight Jeff E. | Officer | F-InKind | D | Common Stock | 587 | 17.12 | 10.0K | 34,400 | — | ↗ |
| 2023-03-16 | Betz Stephen F. | Officer | F-InKind | D | Common Stock | 1,410 | 17.12 | 24.1K | 86,879 | — | ↗ |
| 2023-03-01 | Wilson Marc | Officer | A-Award | A | Stock Option (right to buy) | 112,850 | 19.64 | 2.22M | 112,850 | — | ↗ |
| 2023-03-01 | Struthers Richard Scott | Director / Officer | A-Award | A | Common Stock (right to buy) | 287,700 | 19.64 | 5.65M | 287,700 | — | ↗ |
| 2023-03-01 | Pizzuti Dana | Officer | A-Award | A | Common Stock | 4,500 | 0.00 | — | 17,000 | — | ↗ |
| 2023-03-01 | Krasner Alan Seth | Officer | A-Award | A | Common Stock | 19,500 | 0.00 | — | 43,988 | — | ↗ |
| 2023-03-01 | Knight Jeff E. | Officer | A-Award | A | Stock Option (right to buy) | 91,000 | 19.64 | 1.79M | 91,000 | — | ↗ |
| 2023-03-01 | Hassard James | Officer | A-Award | A | Common Stock | 14,000 | 0.00 | — | 14,000 | — | ↗ |
| 2023-03-01 | Betz Stephen F. | Officer | A-Award | A | Common Stock | 23,600 | 0.00 | — | 88,289 | — | ↗ |
| 2023-02-01 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 19.59 | 61.2K | 64,689 | — | ↗ |
| 2023-01-25 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 8,336 | 21.07 | 175.6K | 67,815 | — | ↗ |
| 2023-01-17 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 18.00 | 56.3K | 76,151 | — | ↗ |
| 2023-01-03 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 18.35 | 57.4K | 79,277 | — | ↗ |
| 2022-12-31 | Wilson Marc | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Krasner Alan Seth | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-12-31 | Knight Jeff E. | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-12-15 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 16.00 | 50.0K | 82,403 | — | ↗ |
| 2022-12-01 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 17.84 | 55.8K | 84,968 | — | ↗ |
| 2022-11-15 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 18.72 | 58.5K | 88,094 | — | ↗ |
| 2022-11-01 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 18.52 | 57.9K | 91,220 | — | ↗ |
| 2022-10-17 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 17.73 | 55.4K | 94,346 | — | ↗ |
| 2022-10-12 | Struthers Richard Scott | Officer | M-Exempt | D | Incentive stock option (Right to Buy) | 11,100 | 0.00 | — | 161,270 | — | ↗ |
| 2022-10-10 | Pizzuti Dana | Officer | A-Award | A | Stock Option (right to buy) | 230,000 | 0.00 | — | 230,000 | — | ↗ |
| 2022-10-03 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,126 | 19.64 | 61.4K | 97,472 | — | ↗ |
| 2022-09-30 | Pizzuti Dana | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-09-15 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 4,168 | 21.01 | 87.6K | 100,598 | — | ↗ |
| 2022-09-07 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 1,042 | 21.00 | 21.9K | 104,766 | — | ↗ |
| 2022-09-01 | Betz Stephen F. | Officer | J-Other | A | Common Stock | 1,336 | 11.02 | 14.7K | 108,934 | — | ↗ |
| 2022-07-26 | Knight Jeff E. | Officer | S-Sale | D | Common Stock | 1,152 | 20.70 | 23.8K | 4,950 | — | ↗ |
| 2022-07-13 | Fust Matthew K | Director | M-Exempt | D | Non-qualified stock option (Right to Buy) | 5,700 | 1.45 | 8.3K | 0 | — | ↗ |
| 2022-06-17 | WIERENGA WENDALL | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 0.00 | — | 17,500 | — | ↗ |
| 2022-06-17 | Vivaldi Coelho Rogerio | Director | A-Award | A | Stock Option (right to buy) | 8,750 | 0.00 | — | 8,750 | — | ↗ |
| 2022-06-17 | Okey Stephanie | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 18.29 | 320.1K | 17,500 | — | ↗ |
| 2022-06-17 | Nichols Weston | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 18.29 | 320.1K | 17,500 | — | ↗ |
| 2022-06-17 | Fust Matthew K | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 18.29 | 320.1K | 17,500 | — | ↗ |
| 2022-06-17 | Deardorf Caren | Director | A-Award | A | Stock Option (right to buy) | 4,375 | 0.00 | — | 4,375 | — | ↗ |
| 2022-06-17 | Bedrosian Camille L | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 0.00 | — | 17,500 | — | ↗ |
| 2022-05-02 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,247 | 20.10 | 65.3K | 107,598 | — | ↗ |
| 2022-04-18 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 157,515 | 22.22 | 3.50M | 5,321,032 | — | ↗ |
| 2022-04-18 | EDELMAN JOSEPH | Director | P-Purchase | A | Common Stock | 157,515 | 22.22 | 3.50M | 5,321,032 | — | ↗ |
| 2022-04-18 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 5,664 | 25.81 | 146.2K | 110,845 | — | ↗ |
| 2022-04-13 | Struthers Richard Scott | Officer | S-Sale | D | Common Stock | 69,176 | 27.53 | 1.90M | 730,805 | — | ↗ |
| 2022-04-05 | Struthers Richard Scott | Officer | S-Sale | D | Common Stock | 21,357 | 25.34 | 541.2K | 869,448 | — | ↗ |
| 2022-04-04 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 9,000 | 23.97 | 215.8K | 116,509 | — | ↗ |
| 2022-03-31 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 4,164 | 21.06 | 87.7K | 129,673 | — | ↗ |
| 2022-03-15 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,123 | 18.94 | 59.1K | 133,837 | — | ↗ |
| 2022-03-11 | Deardorf Caren | Director | A-Award | A | Stock Option (right to buy) | 35,000 | 19.30 | 675.5K | 35,000 | — | ↗ |
| 2022-03-10 | Hassard James | Officer | A-Award | A | Stock Option (right to buy) | 160,000 | 19.73 | 3.16M | 160,000 | — | ↗ |
| 2022-03-01 | Madan Ajay | Officer | S-Sale | A | Common Stock | 9,000 | 19.88 | 178.9K | 176,995 | — | ↗ |
| 2022-03-01 | Betz Stephen F. | Officer | S-Sale | D | Common Stock | 3,123 | 19.73 | 61.6K | 136,960 | — | ↗ |
| 2022-02-28 | Wilson Marc | Officer | A-Award | A | Common Stock | 19,500 | 0.00 | — | 81,618 | — | ↗ |
| 2022-02-28 | Struthers Richard Scott | Director / Officer | A-Award | A | Common Stock | 53,400 | 0.00 | — | 57,400 | — | ↗ |
| 2022-02-28 | Madan Ajay | Officer | A-Award | A | Common Stock (right to buy) | 65,400 | 20.02 | 1.31M | 65,400 | — | ↗ |
| 2022-02-28 | Krasner Alan Seth | Officer | A-Award | A | Common Stock (right to buy) | 66,500 | 20.02 | 1.33M | 66,500 | — | ↗ |
| 2022-02-28 | Knight Jeff E. | Officer | A-Award | A | Common Stock | 4,950 | 0.00 | — | 4,950 | — | ↗ |
| 2022-02-28 | Hassard James | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-28 | Betz Stephen F. | Officer | A-Award | A | Stock Option (right to buy) | 77,000 | 20.02 | 1.54M | 77,000 | — | ↗ |
| 2022-02-15 | Betz Stephen F. | Officer | S-Sale | D | Common stock | 3,123 | 18.64 | 58.2K | 123,583 | — | ↗ |
| 2022-02-07 | Madan Ajay | Officer | S-Sale | D | Common Stock | 13,411 | 17.83 | 239.1K | 172,045 | — | ↗ |
| 2022-02-01 | Betz Stephen F. | Officer | S-Sale | D | Common stock | 3,123 | 18.79 | 58.7K | 126,706 | — | ↗ |
| 2022-01-19 | Krasner Alan Seth | Officer | S-Sale | D | Common Stock | 6,700 | 21.21 | 142.1K | 8,311 | — | ↗ |
| 2022-01-18 | Betz Stephen F. | Officer | S-Sale | D | Common stock | 4,168 | 23.29 | 97.1K | 128,875 | — | ↗ |
| 2022-01-03 | Vivaldi Coelho Rogerio | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-03 | Betz Stephen F. | Officer | S-Sale | D | Common stock | 7,168 | 28.02 | 200.8K | 133,043 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.8K
Shares Outstanding
104.71M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 718.5K | — | 3.28M | 7.16M | 462.4K | 7.0K | 11.63M | 89.79% | ↗ |
| 2 | 2025 | Tobin Schilke Chief Financial Officer | 452.3K | — | 1.76M | 1.67M | 206.1K | 273.7K | 4.36M | 78.61% | ↗ |
| 3 | 2025 | Dana Pizzuti, M.D. Chief Medical and Development Officer | 573.3K | — | 1.58M | 1.49M | 258.0K | 7.0K | 3.91M | 78.56% | ↗ |
| 4 | 2025 | Stephen F. Betz, Ph.D. Chief Scientific Officer | 520.0K | — | 1.58M | 1.49M | 228.2K | 7.0K | 3.83M | 80.27% | ↗ |
| 5 | 2025 | Jeff Knight Chief Operating Officer | 511.7K | — | 1.58M | 1.49M | 236.0K | 7.0K | 3.83M | 80.28% | ↗ |
| 6 | 2025 | Marc Wilson Former Chief Financial Officer | 119.8K | — | 514.6K | 2.56M | — | 64.0K | 3.26M | 94.35% | ↗ |
| 7 | 2024 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 653.8K | — | 2.83M | 6.64M | 407.8K | 3.0K | 10.53M | 89.89% | ↗ |
| 8 | 2024 | Marc Wilson Chief Financial Officer | 468.9K | — | 1.11M | 2.64M | 211.0K | 3.0K | 4.43M | 84.60% | ↗ |
| 9 | 2024 | Marc Wilson Former Chief Financial Officer | 468.9K | — | 1.11M | 2.64M | 211.0K | 3.0K | 4.43M | 84.60% | ↗ |
| 10 | 2024 | Dana Pizzuti, M.D. Chief Medical and Development Officer | 550.8K | — | 1.00M | 2.41M | 247.9K | 3.0K | 4.21M | 80.96% | ↗ |
| 11 | 2024 | 'Dana Pizzuti, M.D. Chief Development Officer | 550.8K | — | 1.00M | 2.41M | 247.9K | 3.0K | 4.21M | 80.96% | ↗ |
| 12 | 2024 | Stephen F. Betz, Ph.D. Chief Scientific Officer | 491.7K | — | 1.00M | 2.41M | 221.3K | 3.0K | 4.12M | 82.64% | ↗ |
| 13 | 2024 | Jeff Knight Chief Operating Officer | 490.0K | — | 1.00M | 2.41M | 222.0K | 3.0K | 4.12M | 82.66% | ↗ |
| 14 | 2023 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 614.0K | — | 1.21M | 3.56M | 361.3K | 3.0K | 5.75M | 82.98% | ↗ |
| 15 | 2023 | Marc Wilson Former Chief Financial Officer | 450.5K | — | 475.3K | 1.40M | 188.8K | 3.0K | 2.51M | 74.45% | ↗ |
| 16 | 2023 | Marc Wilson Chief Financial Officer | 450.5K | — | 475.3K | 1.40M | 188.8K | 3.0K | 2.51M | 74.45% | ↗ |
| 17 | 2023 | Stephen F. Betz, Ph.D. Chief Scientific Officer | 471.9K | — | 463.5K | 1.36M | 197.7K | 3.0K | 2.50M | 73.06% | ↗ |
| 18 | 2023 | Jeff Knight Chief Operating Officer | 459.2K | — | 579.4K | 1.13M | 195.1K | 3.0K | 2.36M | 72.18% | ↗ |
| 19 | 2023 | Alan Krasner, M.D. Chief Endocrinologist | 459.7K | — | 383.0K | 1.13M | 191.2K | 3.0K | 2.16M | 69.76% | ↗ |
| 20 | 2023 | James Hassard Chief Commercial Officer | 436.7K | — | 275.0K | 807.1K | 183.8K | 3.0K | 1.71M | 63.44% | ↗ |
| 21 | 2023 | Dana Pizzuti, M.D. Chief Medical and Development Officer | 529.2K | — | 88.4K | 259.8K | 221.7K | 3.0K | 1.10M | 31.59% | ↗ |
| 22 | 2023 | 'Dana Pizzuti, M.D. Chief Development Officer | 529.2K | — | 88.4K | 259.8K | 221.7K | 3.0K | 1.10M | 31.59% | ↗ |
| 23 | 2022 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 590.2K | — | 1.07M | 3.66M | 277.5K | 3.0K | 5.60M | 84.46% | ↗ |
| 24 | 2022 | Dana Pizzuti, M.D. Chief Development Officer | 133.2K | 95.0K | 211.1K | 2.90M | 184.8K | 80.6K | 3.61M | 86.32% | ↗ |
| 25 | 2022 | 'Dana Pizzuti, M.D. Chief Development Officer | 133.2K | 95.0K | 211.1K | 2.90M | 184.8K | 80.6K | 3.61M | 86.32% | ↗ |
| 26 | 2022 | James Hassard Chief Commercial Officer | 356.1K | — | — | 2.33M | 121.8K | 3.0K | 2.81M | 82.88% | ↗ |
| 27 | 2022 | Marc Wilson Chief Financial Officer | 432.5K | — | 390.4K | 1.34M | 150.1K | 3.0K | 2.31M | 74.69% | ↗ |
| 28 | 2022 | Stephen F. Betz, Ph.D. Chief Scientific Officer | 453.6K | — | 330.3K | 1.13M | 161.9K | 3.0K | 2.08M | 70.27% | ↗ |
| 29 | 2022 | Alan Krasner, M.D. Chief Endocrinologist | 445.6K | — | — | 1.38M | 150.2K | 3.0K | 1.98M | 69.68% | ↗ |
| 30 | 2022 | Jeff Knight Chief Operating Officer | 412.4K | — | 99.1K | 339.5K | 151.3K | 3.0K | 1.01M | 43.63% | ↗ |
| 31 | 2021 | R. Scott Struthers President and Chief Executive Officer | 567.0K | — | — | 3.24M | 337.1K | 3.0K | 4.14M | 78.11% | ↗ |
| 32 | 2021 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 567.0K | — | — | 3.24M | 337.1K | 3.0K | 4.14M | 78.11% | ↗ |
| 33 | 2021 | Jeff Knight Chief Operating Officer | 136.1K | 40.0K | — | 2.74M | 58.5K | 3.0K | 2.98M | 92.03% | ↗ |
| 34 | 2021 | Ajay Madan Former Chief Development Officer | 430.8K | — | — | 1.44M | 181.0K | 3.0K | 2.06M | 70.11% | ↗ |
| 35 | 2021 | Marc Wilson Chief Financial Officer | 410.8K | — | — | 1.26M | 176.7K | 3.0K | 1.85M | 68.01% | ↗ |
| 36 | 2021 | Alan Krasner, M.D. Chief Endocrinologist | 418.7K | — | — | 676.4K | 181.0K | 3.0K | 1.28M | 52.88% | ↗ |
| 37 | 2020 | R. Scott Struthers, Ph.D. President and Chief Executive Officer | 543.6K | — | — | 3.01M | 276.8K | — | 3.83M | 78.56% | ↗ |
| 38 | 2020 | R. Scott Struthers President and Chief Executive Officer | 543.6K | — | — | 3.01M | 276.8K | — | 3.83M | 78.56% | ↗ |
| 39 | 2020 | Ajay Madan Former Chief Development Officer | 413.0K | — | — | 1.05M | 154.6K | — | 1.62M | 64.96% | ↗ |
| 40 | 2020 | Ajay Madan Chief Development Officer | 413.0K | — | — | 1.05M | 154.6K | — | 1.62M | 64.96% | ↗ |
| 41 | 2020 | Marc Wilson Chief Financial Officer | 384.2K | — | — | 1.05M | 143.5K | — | 1.58M | 66.60% | ↗ |
| 42 | 2020 | Marc. S. Wilson Chief Financial Officer | 384.2K | — | — | 1.05M | 143.5K | — | 1.58M | 66.60% | ↗ |
| 43 | 2019 | R. Scott Struthers | 541.7K | — | — | 3.05M | 173.7K | — | 3.77M | 81.01% | ↗ |
| 44 | 2019 | R. Scott Struthers President and Chief Executive Officer | 541.7K | — | — | 3.05M | 173.7K | — | 3.77M | 81.01% | ↗ |
| 45 | 2019 | Alan Krasner | 421.7K | — | — | 973.8K | 99.0K | 51.3K | 1.55M | 63.00% | ↗ |
| 46 | 2019 | Marc. S. Wilson Chief Financial Officer | 364.7K | — | — | 973.8K | 85.2K | — | 1.42M | 68.39% | ↗ |
| 47 | 2019 | Marc. S. Wilson | 364.7K | — | — | 973.8K | 85.2K | — | 1.42M | 68.39% | ↗ |
| 48 | 2018 | R. Scott Struthers | 409.9K | 110.8K | — | 2.26M | 259.9K | 3.2K | 3.04M | 74.23% | ↗ |
| 49 | 2018 | Alan Krasner | 188.9K | — | — | 1.24M | 75.5K | 63.6K | 1.57M | 79.13% | ↗ |
| 50 | 2018 | Marc. S. Wilson | 272.5K | 25.0K | — | 612.2K | 120.3K | 1.0K | 1.03M | 59.38% | ↗ |
| 51 | 2017 | R. Scott Struthers | 350.0K | 29.0K | — | — | — | 6.3K | 385.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| R. Scott Struthers | Founder, President, Chief Executive Officer & Director | 1M | — |
| Tobin C. Schilke | Chief Financial Officer | 1M | male |
| Stephen F. Betz | Co-Founder & Chief Scientific Officer | 755.2K | — |
| Jeff E. Knight | Chief Development & Operating Officer | 715.0K | male |
| Alan S. Krasner | Chief Endocrinologist | 653.9K | — |
| Kevin Capps | Head of Intellectual Property | — | male |
| Robert Cuddihy | Senior Vice President of Medical Affairs | — | — |
| Kea Lingo | Chief Information Officer | — | male |
| Chris Robillard | Chief Business Officer | — | male |
| Garlan Adams | Chief Legal Officer & Corporate Secretary | — | female |
| Gayathri Diwakar | Senior Director of Investor Relations | — | female |
| Adriana Cabre | Chief Human Resources Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-09-25 | 2024-10-03 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CRNX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
